Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Accumulated Expenses (2019 - 2025)

Bioadaptives' Other Accumulated Expenses history spans 6 years, with the latest figure at $1018.0 for Q2 2025.

  • For Q2 2025, Other Accumulated Expenses changed 0.39% year-over-year to $1018.0; the TTM value through Jun 2025 reached $1018.0, changed 0.39%, while the annual FY2024 figure was $1021.0, 0.2% changed from the prior year.
  • Other Accumulated Expenses for Q2 2025 was $1018.0 at Bioadaptives, roughly flat from $1019.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1022.0 in Q2 2024 and bottomed at $1015.0 in Q4 2022.
  • The 4-year median for Other Accumulated Expenses is $1019.0 (2023), against an average of $1019.0.
  • The largest annual shift saw Other Accumulated Expenses increased 0.39% in 2023 before it fell 0.39% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $1015.0 in 2022, then grew by 0.39% to $1019.0 in 2023, then rose by 0.2% to $1021.0 in 2024, then decreased by 0.29% to $1018.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other Accumulated Expenses are $1018.0 (Q2 2025), $1019.0 (Q1 2025), and $1021.0 (Q4 2024).